UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

Headache, 2012-11, Vol.52 (10), p.1456-1470

2012

Volltextzugriff (PDF)

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Headache, 2010-06, Vol.50 (6), p.921-936

2010

Volltextzugriff (PDF)

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

Headache, 2010-10, Vol.50 (9), p.1406-1418

2010

Volltextzugriff (PDF)

Relationship Between Disability and Health-Related Quality of Life and Caregiver Burden in Patients With Upper Limb Poststroke Spasticity

PM & R, 2012, Vol.4 (1), p.4-10

2012

Volltextzugriff (PDF)

Pooled Analysis of the Safety of Botulinum Toxin Type A in the Treatment of Poststroke Spasticity

Archives of physical medicine and rehabilitation, 2006-06, Vol.87 (6), p.786-792

2006

Volltextzugriff (PDF)

Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact

Medicine (Baltimore), 2023-07, Vol.102 (S1), p.e32376-e32376

2023

Volltextzugriff (PDF)

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

Journal of neurology, neurosurgery and psychiatry, 2015-09, Vol.86 (9), p.996-1001

2015

Volltextzugriff (PDF)

Depression and risk of transformation of episodic to chronic migraine

Journal of headache and pain, 2012-11, Vol.13 (8), p.615-624

2012

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Journal of the neurological sciences, 2013-08, Vol.331 (1), p.48-56

2013

Volltextzugriff (PDF)

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

Headache, 2011-10, Vol.51 (9), p.1358-1373

2011

Volltextzugriff (PDF)

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact

Medicine (Baltimore), 2023-07, Vol.102 (S1), p.e32600-e32600

2023

Volltextzugriff (PDF)

Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C-dAS)

Headache, 2011-05, Vol.51 (5), p.693-706

2011

Volltextzugriff (PDF)

Development of onabotulinumtoxinA for chronic migraine

Annals of the New York Academy of Sciences, 2014-11, Vol.1329 (1), p.67-80

2014

Volltextzugriff (PDF)

Formation of neutralizing antibodies in patients receiving botulinum toxin type a for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials

Clinical therapeutics, 2007-04, Vol.29 (4), p.683-690

2007

Volltextzugriff (PDF)

Assessing Clinically Meaningful Treatment Effects in Controlled Trials: Chronic Migraine as an Example

The journal of pain, 2015-02, Vol.16 (2), p.164-175

2015

Volltextzugriff (PDF)

Improving the Classification of Migraine Subtypes: An Empirical Approach Based on Factor Mixture Models in the American Migraine Prevalence and Prevention (AMPP) Study

Headache, 2014-05, Vol.54 (5), p.830-849

2014

Volltextzugriff (PDF)

Botulinum Toxin Type A for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

Mayo Clinic proceedings, 2005-09, Vol.80 (9), p.1126-1137

2005

Volltextzugriff (PDF)

OnabotulinumtoxinA for Treatment of Chronic Migraine: A Response

Headache, 2011-06, Vol.51 (6), p.1005-1008

2011

Volltextzugriff (PDF)

AUTHOR RESPONSE

Headache, 2011-06, Vol.51 (6), p.1003-1005

2011

Volltextzugriff (PDF)

Article 13: The Effect of Repeated Treatment of Botulinum Toxin Type A on Poststroke, Spasticity-Related Pain: A Subgroup Analysis of Patients in a 12-Month Trial

Archives of physical medicine and rehabilitation, 2007, Vol.88 (10), p.e4-e4

2007

Volltextzugriff (PDF)

Poster 385: Degree of Disability Due to Upper Limb Post-Stroke Spasticity (UL PSS) is Associated with Physical and Psychological Functioning

PM & R, 2009-09, Vol.1 (9), p.S271-S272

2009

Volltextzugriff (PDF)

Poster 418: Hygiene and Dressing Disability Associated with Greater Caregiver Time Among Patients with Upper Limb Post-Stroke Spasticity

PM & R, 2009-09, Vol.1 (9), p.S286-S286

2009

Volltextzugriff (PDF)

Poster 408: Severity of Disability is Associated with Lower Health-Related Quality of Life (HRQoL) Among Patients with Upper Limb Post-Stroke Spasticity (UL PSS)

PM & R, 2009-09, Vol.1 (9), p.S281-S282

2009

Volltextzugriff (PDF)

8. An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models

Toxicon (Oxford), 2015-01, Vol.93, p.S4-S4

2015

Volltextzugriff (PDF)

Dichloroacetate: Population Pharmacokinetics with a Pharmacodynamic Sequential Link Model

Journal of clinical pharmacology, 2001-03, Vol.41 (3), p.259-267

2001

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Female
(18)
Male
(18)
Adult
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Middle Aged
(14)
Neurology
(14)
Rehabilitation
(14)
Botulinum Toxins, Type A - Therapeutic Use
(12)
Clinical Neurology
(12)
Neurosciences & Neurology
(12)
Aged
(11)
Botulinum Toxin Type A
(11)
Vascular Diseases And Vascular Malformations Of The Nervous System
(11)
Chronic Migraine
(10)
Double-Blind Method
(10)
Chronic Disease
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

Relationship Between Disability and Health-Related Quality of Life and Caregiver Burden in Patients With Upper Limb Poststroke Spasticity

Pooled Analysis of the Safety of Botulinum Toxin Type A in the Treatment of Poststroke Spasticity

Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

Depression and risk of transformation of episodic to chronic migraine

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact

Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C-dAS)

Development of onabotulinumtoxinA for chronic migraine

Formation of neutralizing antibodies in patients receiving botulinum toxin type a for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials

Assessing Clinically Meaningful Treatment Effects in Controlled Trials: Chronic Migraine as an Example

Improving the Classification of Migraine Subtypes: An Empirical Approach Based on Factor Mixture Models in the American Migraine Prevalence and Prevention (AMPP) Study

Botulinum Toxin Type A for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

OnabotulinumtoxinA for Treatment of Chronic Migraine: A Response

AUTHOR RESPONSE

Article 13: The Effect of Repeated Treatment of Botulinum Toxin Type A on Poststroke, Spasticity-Related Pain: A Subgroup Analysis of Patients in a 12-Month Trial

Poster 385: Degree of Disability Due to Upper Limb Post-Stroke Spasticity (UL PSS) is Associated with Physical and Psychological Functioning

Poster 418: Hygiene and Dressing Disability Associated with Greater Caregiver Time Among Patients with Upper Limb Post-Stroke Spasticity

Poster 408: Severity of Disability is Associated with Lower Health-Related Quality of Life (HRQoL) Among Patients with Upper Limb Post-Stroke Spasticity (UL PSS)

8. An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models

Dichloroacetate: Population Pharmacokinetics with a Pharmacodynamic Sequential Link Model

Suchergebnisse filtern